Francis deSouza, who was the CEO of Illumina until June 2023, has a solid background in technology, holding a Bachelor's in Computer Science from the University of California, Berkeley. His journey at Illumina began when he joined as President and...

Francis deSouza, who was the CEO of Illumina until June 2023, has a solid background in technology, holding a Bachelor's in Computer Science from the University of California, Berkeley. His journey at Illumina began when he joined as President and was elected to the Board of Directors in 2014. Under his leadership, the company focused heavily on performance-driven outcomes, yielding impressive financial results that contributed to his substantial compensation package. In 2023 alone, deSouza earned nearly $14.5 million, with most of that coming from stock awards, highlighting how aligned his interests were with the company's performance. Over the years, his decision to sell stock has shown notable fluctuations, swinging significantly from about $19 million in asset value at the peak, down to values around $16 million in more recent months, reflecting market variations. deSouza's tenure at Illumina was defined by a commitment to growth and innovation in genomic technologies, steering the company through a rapidly evolving industry. His strategic vision and technical expertise have left a lasting mark on Illumina's trajectory, influencing the broader landscape of biotechnology.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Illumina CEOs

I

Francis deSouza

Ex-CEO of Illumina

Field of Expertise

Technology & Engineering - Technology

Sector of Economy

Healthcare

CEO of Illumina for

7 years 4 months (Jan 2016 - Jun 2023)

Previous Experience

President of Illumina, Inc.

Rivals

Competitors/colleagues of Francis deSouza

Holdings

See how much did Francis deSouza make over time.

Francis deSouza's holdings in Illumina showed significant fluctuations over the years. At one point in 2021, they reached a high of approximately $38.58 million. Recently, they've decreased somewhat, hovering around $17 million as of late 2023. His decisions to sell...

Francis deSouza's holdings in Illumina showed significant fluctuations over the years. At one point in 2021, they reached a high of approximately $38.58 million. Recently, they've decreased somewhat, hovering around $17 million as of late 2023. His decisions to sell stock at times reflect confidence in market timing, moving assets from highs of over $30 million to values closer to $16 million in the current climate. This variation illustrates both the challenges and opportunities that come with leading a publicly traded biotech firm, where stock performance is closely tied to broader market trends and company performance.

Total Stock Sold

$25.67M

ILMN

$25.67M

81,000 ILMN shares

What if they kept their stock?

If Francis deSouza didn't sell their stock, today they would have:
Extra ILMN81,000 shares worth $23.45M.
This is -8.65% and $2.22M less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Francis deSouza.

DIS

$93.95K

DIS at $116.95/share

Mar 31, 2024

Received

DIS

$91.25K

DIS at $91.79/share

Dec 31, 2023

Received

DIS

$91.25K

DIS at $81.87/share

Sep 30, 2023

Received

DIS

$91.25K

DIS at $89.17/share

Jun 30, 2023

Received

DIS

$91.25K

DIS at $96.05/share

Mar 31, 2023

Received

ILMN

31,480 shares

ILMN

Mar 1, 2023

Received

DIS

$91.26K

DIS at $86.92/share

Dec 31, 2022

Received

DIS

$91.25K

DIS at $101.28/share

Sep 30, 2022

Received

DIS

$91.26K

DIS at $95.24/share

Jun 30, 2022

Received

DIS

$91.25K

DIS at $139.57/share

Mar 31, 2022

Received

Compensation History

See how much did Francis deSouza make over time.

In 2023, Francis deSouza earned a total of about $14.5 million, predominantly through stock awards, which accounted for nearly 97% of his compensation. His base salary was $518,354, but the absence of a bonus this year highlights a shift towards focusing entirely on long-term performance through stock grants. This approach aligns with his philosophy of Pay for Performance, aiming to motivate executives to drive company success. Even in previous years, his pay saw substantial variation, from over $33 million in 2021 to around $3.3 million in 2019, illustrating how closely his earnings are tied to the company's performance metrics. This model not only incentivizes him but ensures that his financial success is intrinsically linked to Illumina's growth and innovation.

Year

2023

Total Compensation

$14.49M

Salary

$518.35K

Board Justification

The compensation philosophy is designed to achieve four key objectives: Pay for Performance, Alignment of Interests, Competitive Rewards, and Retention.

Bonus

$0.00

Board Justification

No cash incentive amounts were paid with respect to the 2023 and 2022 2H performance periods, and Mr. deSouza did not receive a cash incentive payment in 2023.

Other

$6.78K

Board Justification

These amounts represent Company contributions to 401(k) plans, Company contributions to the non-qualified deferred compensation plan for a 401(k) match true-up, Company-paid physical exams and long-term disability premiums.

Restricted Stock

$13.97M(13.97M RSU)

Board Justification

This reflects the grant date fair value of stock awards granted during fiscal 2023, computed in accordance with FASB ASC Topic 718, based on the closing stock price on the grant date.

Performance Metrics

Performance metrics include preset annual financial goals for cash incentives and long-term performance goals for equity incentives.

Other Illumina CEOs

Here are other CEOs of Illumina

Charles Dadswell

Ex-CEO of Illumina

June 2023 - September 2023